Carregant...
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
The AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy that appears to have arisen at an early stage during eukaryotic evolution. In 2001 it was shown to be activated by metformin, currently the major drug for treatment for type 2 diabetes. Although the known metabol...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3712072/ https://ncbi.nlm.nih.gov/pubmed/23801715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db13-0368 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|